Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $27.04 Analyst target: $48.50 Upside: 79.36%
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high-frequency chest wall oscillation (HFCWO) therapy in lung care for patients of all ages in the United States. and internationally. The company is headquartered in New Prague, Minnesota.
See the full interactive analysis & chart →Informational only — not investment advice.